Newleos Therapeutics, Inc., a clinical-stage biotechnology company developing innovative treatments for neuropsychiatric ...

The launch of the first phase of a new study conducted by the global leader in English language testing, OET in collaboration ...

Chest pain ranks as the second most common reason for emergency department (ED) visits, making it a key concern for patients ...

Who Can Prescribe Anxiety Medication? Whether it shows in consistent panic attacks or the occasional flare-up, anxiety can be ...

The growing cannabis legalization has translated into an increased awareness of the plant’s medicinal properties. More people are now talking about marijuana than before, an excellent development for ...

Nurse practitioner-led integrated care programs significantly alleviate depression and anxiety in rural university students, ...

Did you know you can do a quick test in just 10 minutes to see if someone could have depression or anxiety? All you need to ...

Work anxiety is more common than many people realize. If you work in a high-stress environment and feel on edge during your ...

Chest pain ranks as the second most common reason for emergency department (ED) visits, making it a key concern for patients ...

Last patient last visit (LPLV) milestone in AFFIRM-1 Phase 3 trial of BNC-210 in social anxiety disorder (SAD) achieved; topline readout ...

AjD Represents an Area of Significant Unmet Need; No U.S. Food and Drug Administration(FDA)-Approved Therapies Available -- ...